The FITC, a society created in 2019, aims to bring together actors and initiatives in immunotherapy working towards the success of cancer treatment. In particular, a working group is dedicated to create partnerships with patient associations to organize events for patient support, to provide up-to-date information about novel therapeutics and to support patient advocacy while dealing with regulatory authorities. The FITC aims to empower patients for better access to treatment and management of their disease.